$1.46
0.010.69%
Last update: Oct 7, 1:12 PM
$1.42
-0.0275-1.9%
Bionano Genomics Inc
BNGONASDAQ
Bionano Genomics (BNGO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bionano Genomics (BNGO) last issued guidance on August 10, 2026 for fiscal year 2026. The company guided revenue in the range of $31M - $33M for the period.
Compared to prior guidance, Bionano Genomics raised its revenue forecast from a prior range of $30M - $33M.
Bionano Genomics has issued 36 guidance updates between November 3, 2022 and August 10, 2026. During this period, the company raised its outlook 12 times and lowered it 16 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.68 | $-0.92 | $-2.81 | $-2.13 |
| Actual | $-0.64 | $-0.76 | $-0.77 | $-1.59 |
| Surprise | +5.88% | +17.4% | +72.6% | +25.4% |
| Revenue | ||||
| Estimate | $7.5M | $6.6M | $7.9M | $6.9M |
| Actual | $8.2M | $6.7M | $8.0M | $7.4M |
| Surprise | +9.30% | +2.03% | +0.80% | +7.33% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.47 | $-0.41 |
| Revenue | ||
| Consensus | $8.4M | $9.4M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.64 | $-0.68 | 5.88 % |
| Q1 | May 13, 2026 | $-0.76 | $-0.92 | 17.4 % |
| Q4 | Mar 23, 2026 | $-0.77 | $-2.81 | 72.6 % |
| Q3 | Nov 13, 2025 | $-1.59 | $-2.13 | 25.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $8.17M | $7.48M | 9.30 % |
| Q1 | May 13, 2026 | $6.69M | $6.55M | 2.03 % |
| Q4 | Mar 23, 2026 | $7.95M | $7.89M | 0.80 % |
| Q3 | Nov 13, 2025 | $7.37M | $6.86M | 7.33 % |
